TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive NCI Hits Grant Targets, But Labs Feel The Pain Of Budget Cuts, Director Says. November 23, 2007
TCL Archive Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research January 28, 1994
